Takeda Pharmaceutical's IFRS net income for 9 months of fiscal year 2021 was JP¥241.541 billion, up 34.9% from JP¥179.027 billion in the previous year. Revenue rose 11% to JP¥2.696 trillion compared to JP¥2.428 trillion a year earlier.